2019冠状病毒病中的糖尿病：患病率、病理生理学、预后及实际考量
Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations.
作者信息
Singh Awadhesh Kumar, Gupta Ritesh, Ghosh Amerta, Misra Anoop
机构信息
G.D Hospital and Diabetes Institute, Kolkata, India.
Fortis CDOC Hospital, Chirag Enclave, New Delhi, India.
出版信息
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):303-310. doi: 10.1016/j.dsx.2020.04.004. Epub 2020 Apr 9.
BACKGROUND AND AIMS
High prevalence of diabetes makes it an important comorbidity in patients with COVID-19. We sought to review and analyze the data regarding the association between diabetes and COVID-19, pathophysiology of the disease in diabetes and management of patients with diabetes who develop COVID-19 infection.
METHODS
PubMed database and Google Scholar were searched using the key terms 'COVID-19', 'SARS-CoV-2', 'diabetes', 'antidiabetic therapy' up to April 2, 2020. Full texts of the retrieved articles were accessed.
RESULTS
There is evidence of increased incidence and severity of COVID-19 in patients with diabetes. COVID-19 could have effect on the pathophysiology of diabetes. Blood glucose control is important not only for patients who are infected with COVID-19, but also for those without the disease. Innovations like telemedicine are useful to treat patients with diabetes in today's times.
背景与目的
糖尿病的高患病率使其成为新冠肺炎患者的一种重要合并症。我们试图回顾和分析有关糖尿病与新冠肺炎之间关联的数据、糖尿病患者中该疾病的病理生理学以及感染新冠肺炎的糖尿病患者的管理情况。
方法
截至2020年4月2日，使用关键词“COVID-19”“SARS-CoV-2”“糖尿病”“抗糖尿病治疗”在PubMed数据库和谷歌学术上进行检索。获取检索到的文章的全文。
结果
有证据表明糖尿病患者中新冠肺炎的发病率和严重程度有所增加。新冠肺炎可能会影响糖尿病的病理生理学。血糖控制不仅对感染新冠肺炎的患者很重要，对未感染该疾病的患者也很重要。在当今时代，远程医疗等创新手段对于治疗糖尿病患者很有用。
Zotero 插件